
Why do my kappa and lambda levels stay low even with treatment?
In this video, Dr. Brian GM Durie explains why kappa and lambda levels typically decrease for myeloma patients. BOTTOM LINE: |
|||
Have a question? Submit it to AskDrDurie@myeloma.org |
|||
IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org! |
Previous Post
Global Collaboration Essential to Achieve a Cure for Myeloma
Next Post
Why expertise is important in guiding treatment planning, myeloma research, and much more